Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 27, 2015 07:00 ET | Source: Amicus Therapeutics, Inc.

Amicus Therapeutics Appoints David Allsop as Senior Vice President, International

Industry Veteran With Extensive International Commercial Experience Former SVP, Europe & Canada at Biogen CRANBURY, N.J., April 27, 2015 (GLOBE NEWSWIRE) -- Amicus Therapeutics...
April 09, 2015 07:30 ET | Source: Amicus Therapeutics, Inc.

Amicus Therapeutics Honors Fabry Disease Awareness Month and International Pompe Day

CRANBURY, N.J., April 9, 2015 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, will support several...
March 19, 2015 06:00 ET | Source: Amicus Therapeutics, Inc.

Amicus Therapeutics Provides Positive Global Regulatory Updates From EMA and FDA Meetings for Fabry Monotherapy

MAA Submission for Full Approval Planned in European Union – Company to Accelerate Submission Timeline for MAA Filing to 2Q15 NDA Submission for Accelerated Approval (Subpart H) Planned in...
March 03, 2015 16:01 ET | Source: Amicus Therapeutics, Inc.

Amicus Therapeutics Announces Full-Year 2014 Financial Results and Corporate Updates

MAA Submission for Migalastat Monotherapy for Fabry Disease on Track for Mid-2015 – FDA Meeting Scheduled in 1Q15 to Discuss U.S. Pathway Next-Generation Pompe ERT Set to Enter Clinic in...
February 26, 2015 08:47 ET | Source: Amicus Therapeutics, Inc.

Amicus Therapeutics to Present at Cowen and Company 35th Annual Health Care Conference

CRANBURY, N.J., Feb. 26, 2015 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of rare and orphan diseases, today announced that John F. Crowley,...
February 25, 2015 09:12 ET | Source: Amicus Therapeutics, Inc.

Amicus Therapeutics to Announce Full-Year 2014 Financial Results on March 3, 2015

CRANBURY, N.J., Feb. 25, 2015 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) today announced a conference call and live audio webcast on Tuesday, March 3, 2015 at 5:00 p.m. ET to discuss...
February 10, 2015 07:01 ET | Source: Amicus Therapeutics, Inc.

Amicus Therapeutics Announces Additional Positive Phase 3 Fabry Data on Patient Reported Outcomes at WORLDSymposium(TM) 2015

ORLANDO, Fla. and CRANBURY, N.J., Feb. 10, 2015 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, today...
February 10, 2015 07:00 ET | Source: Amicus Therapeutics, Inc.

Amicus Therapeutics Presents Preclinical Data on Next-Generation Pompe ERT at WORLDSymposium(TM) 2015

Optimized for Efficient Targeting to Multiple Key Muscle Tissues of Disease Significantly Better Than Approved ERT in Reducing Disease Substrate (Glycogen) Addition of Chaperone Further...
February 04, 2015 16:00 ET | Source: Amicus Therapeutics, Inc.

Amicus Therapeutics to Present at Leerink Global Healthcare Conference

CRANBURY, N.J., Feb. 4, 2015 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of rare and orphan diseases, today announced that Chip Baird, Chief...
January 26, 2015 07:30 ET | Source: Amicus Therapeutics, Inc.

Amicus Therapeutics Announces Presentations and Posters at Lysosomal Disease Network WORLD Symposium

CRANBURY, N.J., Jan. 26, 2015 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of rare and orphan diseases, today announced that 2 oral presentations...